Abstract:
The double burden of diabetes mellitus (DM) and pulmonary tuberculosis (TB) is a
global health challenge. Its management differs from that of either disease alone.
Tuberculosis treatment regimens (Rifampicin and Isoniazid) interact with oral antidiabetic drugs resulting in suboptimal glycemic control. Also, the suboptimal control
of diabetes predisposes the patient to tuberculosis and poor response to anti-TB
treatment. Diabetes Mellitus and Tuberculosis, therefore, interact with each other at
multiple levels, each exacerbating the other. The objective of this study are to
determine the burden of diabetes mellitus among newly diagnosed tuberculosis
patients. The study was carried out in Kiambu and Nairobi counties in Kenya
between February 2014 and August 2015. Patients above 15 yeas who tested positive
for Mycobacterium Tuberculosis complex on sputum smear microscopy at the time
of diagnosis were eligible to participate. We obtained clinical and social
demographic data from a semi-structured questionnaire by abstracting patients'
medical records from the National TB program database at 2, 3, 5, and 6 months of
treatment therapy monitoring. The study enrolled 347 patients. We dropped 7/347
patients that had Mycobacterium Bovis from the analysis. The remaining 340
patients: 84% were cured, 7% completed therapy, and 9% had unfavourable
outcomes, out of which 4% (n= 32) had a microbiologic failure. DM prevalence
(HbA1c > 6%) among TB infected patients was 37.2%. The number of cigarettes
smoked per day, and the value of the BUN were significant risk factors for
developing DM among TB patients (P values = 0.045). Of the seven identified TB
strains within the two counties, East Asia, Beijing, Euro America, and Indo Oceanic
were dominant, accounting for 92.4% of infections. DM was not a significant factor
in increasing the likelihood of PTB patients to cluster according to the genotype of
the infecting M. tuberculosis bacillus. The Classification and Regression Tree
(CART) identified the three HbAIc cut off levels depicting the U shaped pattern that
interacted with both weight and BMI. The entire cohort revealed that 8/11 (73%) of
the patient with >2.95%, 111/114 (97%) with HbA1c 2.95-4.55%, and >4.55%
containing 189/215 (88%) of patients who experienced microbiological failure. It is
important to screen all newly diagnosed tuberculosis patients for diabetes mellitus as
they require close monitoring for the control of both diseases, and health policies
should be considered to assess the impact of DM. The study findings demonstrate the
feasibility and the value of screening TB patients for DM in a predominantly health
facility. The findings from this study will also be useful for national scale-up using
simple diagnostic technology in place at the start of screening activities and that it
needs to be a high priority area for implementation as a routine in all primary
caregivers